Trial Profile
A compassionate use study of lorcaserin in paediatric patients with Dravet syndrome.
Status:
Completed
Phase of Trial:
Clinical Phase Unknown
Latest Information Update: 13 Jun 2017
Price :
$35
*
At a glance
- Drugs Lorcaserin (Primary)
- Indications Dravet syndrome
- Focus Therapeutic Use
- 13 Jun 2017 New trial record